stem cell trials
Texas Stem Cell Law Opens Door for Controversial Treatments
Texas Stem Cell Law Opens Door for Controversial Treatments
Anna Azvolinsky | Mar 27, 2018
The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.
CIRM Ups Translational Velocity
CIRM Ups Translational Velocity
Bob Grant | Dec 21, 2015
California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.
Heart Strings
Heart Strings
The Scientist Staff | May 1, 2015
An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients
Hearts on Trial
Hearts on Trial
Kerry Grens | May 1, 2015
As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.
Stem Cell Trial for Eye Disease Commences
Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Done with Immunosuppressants
Done with Immunosuppressants
Jef Akst | Jul 3, 2014
Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.
Geron hESC Trial to Resume?
Geron hESC Trial to Resume?
Jef Akst | May 27, 2014
Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.
More Evidence of Stem Cell Errors
More Evidence of Stem Cell Errors
Kerry Grens | Feb 25, 2014
A committee at the University of Düsseldorf finds misconduct in cardiologist Bodo-Eckehard Strauer’s work.  
Stem-Cell Clinic Moves to Mexico
Stem-Cell Clinic Moves to Mexico
Dan Cossins | Feb 1, 2013
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
 
Opinion: Regenerating Safely
Opinion: Regenerating Safely
Dan Orlando | Jan 21, 2013
Patient safety is paramount in regulating new stem cell treatments.